1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Abbott Acquires Alere

M&A Deal Summary

Abbott Acquires Alere

On February 1, 2016, Abbott acquired healthcare services company Alere for 5.8B USD

Acquisition Highlights
  • This is Abbott’s 1st transaction in the Healthcare Services sector.
  • This is Abbott’s 5th largest (disclosed) transaction.
  • This is Abbott’s 22nd transaction in the United States.
  • This is Abbott’s 3rd transaction in Massachusetts.

M&A Deal Summary
Date 2016-02-01
Target Alere
Sector Healthcare Services
Buyer(s) Abbott
Deal Type Add-on Acquisition
Deal Value 5.8B USD
Advisor(s) J.P. Morgan Securities (Financial)
Cravath, Swaine & Moore (Legal)

Target

Alere

Waltham, Massachusetts, United States
Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere was founded in 1981 and is based in Waltham, Massachusetts.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Abbott

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 42.0B USD (2024)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 29 of 36
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 29 of 36
State: Massachusetts M&A 3 of 3
Country: United States M&A 22 of 29
Year: 2016 M&A 1 of 3
Size (of disclosed) 5 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-30 Tendyne Holdings

Roseville, Minnesota, United States

Tendyne Holdings, Inc. is a medical device company focused on developing minimally invasive mitral valve replacement therapies.

Buy $250M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-05 Kalila Medical

Campbell, California, United States

Kalila Medical, Inc. is a medical device company developing next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders, including atrial fibrillation.

Buy -
Mergr

Solution for

Product

Company

Legal